AI assistant
BRUKER CORP — Director's Dealing 2021
Aug 18, 2021
31067_dirs_2021-08-18_34683ede-7413-4301-ab6c-5e2ff33ae4d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BRUKER CORP (BRKR)
CIK: 0001109354
Period of Report: 2021-08-16
Reporting Person: LAUKIEN FRANK H (Director, CEO, President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-16 | Common Stock | M | 129284 | $24.4090 | Acquired | 38516013 | Direct |
| 2021-08-16 | Common Stock | S | 71594 | $83.8307 | Disposed | 38444419 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-16 | Stock Option (Right to Buy) | $24.4090 | M | 129284 | Disposed | 2021-10-04 | Common Stock (129284) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 492 | Indirect |
| Common Stock | 337087 | Indirect |
| Common Stock | 336607 | Indirect |
| Common Stock | 71728 | Indirect |
| Common Stock | 1046499 | Indirect |
| Common Stock | 201702 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of 1,046,499 shares held by the reporting person's former spouse, 492 shares held by the reporting person's spouse, 337,087 shares held by the reporting person's adult son and 336,607 shares held by the reporting person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2: The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
F3: Reflects shares sold to cover the Reporting Person's exercise price and tax liability in connection with the exercise of stock options.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.76 to $84.04, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.